The most popular peptides currently

1. Tirzepatide

Tirzepatide is a dual GLP-1 and GIP receptor agonist widely studied for its effects on glucose metabolism, appetite regulation,and body composition. It promotes metabolic balance and insulin sensitivity in research models.Compared with earlier incretin analogues, Tirzepatide demonstrates superior dual-receptor synergy,showing remarkable improvements in glycemic control and adipose tissue modulation.

  • Starting dose: 2.5–5 mg once weekly
  • Cycle duration: 8–16 weeks
  • Focus: Glucose & metabolic regulation

2. Retatrutide

Retatrutide is a triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors simultaneously. It is being explored for its synergistic role in energy metabolism and body composition research.Educational studies suggest Retatrutide may produce amplified metabolic signaling, making it a next-generation incretin-class peptide.

  • Starting dose: 2–4 mg weekly
  • Cycle duration: 8–12 weeks
  • Focus: Multi-pathway metabolic modulation

3. Tesamorelin

Tesamorelin is a growth hormone–releasing hormone (GHRH) analogue studied for stimulating natural GH secretion.It supports lean tissue development and lipid metabolism in controlled laboratory settings.Researchers use it to observe GH axis activation and body composition improvements linked to fat distribution.

  • Starting dose: 1 mg daily
  • Cycle duration: 8–12 weeks
  • Focus: GH axis & lipolytic research

4. NAD+

Nicotinamide Adenine Dinucleotide (NAD+) is a coenzyme essential for mitochondrial respiration and cellular repair.It serves as a central component in redox reactions and sirtuin activation. Laboratory studies emphasize NAD+ replenishment for its potential to restore energy output and support DNA integrity in aging research.

  • Starting dose: 100–300 mg daily
  • Cycle duration: 4–8 weeks
  • Focus: Cellular energy & mitochondrial studies

5. MOTS-C

MOTS-C is a mitochondrial peptide involved in regulating insulin sensitivity, metabolic adaptation, and oxidative balance.It plays a role in energy homeostasis under stress conditions. It’s often researched for its potential to improve exercise endurance and support healthy glucose handling.

  • Starting dose: 5–10 mg, 2–3x weekly
  • Cycle duration: 6–10 weeks
  • Focus: Mitochondrial & metabolic optimization

6. TB-500 (Thymosin Beta-4)

TB-500 is a synthetic version of Thymosin Beta-4, known for promoting tissue regeneration, cell migration,and angiogenesis in injury recovery models.Studies examine its potential to accelerate healing, reduce inflammation, and enhance flexibility in soft tissue structures.

  • Starting dose: 5–10 mg weekly
  • Cycle duration: 4–6 weeks (loading) + maintenance
  • Focus: Tissue repair & inflammation control

7. BPC-157

BPC-157 (Body Protection Compound-157) is a gastric-derived peptide widely studied for its regenerative effects ontendons, ligaments, and the gastrointestinal tract.Research indicates that BPC-157 enhances angiogenesis, modulates inflammatory pathways, and accelerates healing response.

  • Starting dose: 250–500 mcg daily
  • Cycle duration: 4–8 weeks
  • Focus: Regeneration & gut barrier studies

8. AOD-9604

AOD-9604 is a modified fragment of human growth hormone (176-191) designed for targeted lipolytic effects withoutsystemic GH elevation.It’s researched for supporting metabolic efficiency and reducing adipose storage via selective fat-cell signaling.

  • Starting dose: 300 mcg daily
  • Cycle duration: 8–12 weeks
  • Focus: Fat metabolism & lipid turnover

9. GLOW & KLOW

GLOW and KLOW peptides are complementary compounds explored for their potential in promoting cellular balance,liver optimization, and metabolic harmony. They represent next-generation regulatory peptides for whole-system research involving cellular repair and energy modulation.

  • Starting dose: 200–400 mcg combined, 3x weekly
  • Cycle duration: 6–10 weeks
  • Focus: Cellular balance & metabolic regulation

10. Cagrilintide

Cagrilintide is an amylin analogue peptide that regulates satiety and caloric intake by influencing hypothalamic pathways. It’s often studied alongside GLP-1 agonists for enhanced appetite suppression and energy regulation.

  • Starting dose: 0.3–1 mg weekly
  • Cycle duration: 8–12 weeks
  • Focus: Appetite & weight-regulation studies



    Research Use Only:

This material is for educational laboratory reference only. It does not constitute usage or medical advice.

 

Back to blog